KP 2.4.5.2 (1) Limfoma Non Hodgkin Dan Hodgkin
KP 2.4.5.2 (1) Limfoma Non Hodgkin Dan Hodgkin
DAN
KEMOTERAPI
IRZA WAHID
SUBBAGIAN HEMATOLOGI ONKOLOGI MEDIK
BAGIAN ILMU PENYAKIT DALAM
FK UNAND RS DR M DJAMIL PADANG
DEFINISI
King Hussein of
Jordan
Mr. T
(Lawrence Tureaud)
Lymphoid generation
Non Burkitts
Lymphocyte
Lymphoplasmocytoid
Plasma cell
KLASIFIKASI
Penggolongan histologi LNH
merupakan masalah yang rumit
dan sukar.
Perkembangan terakhir klasifikasi
yang banyak dipakai adalah
formulasi praktis ( working
formulation = WF 1982 ) dan
Revised Europe American
Classification of Lymphoid
Neoplasms / World Health
Lymphoma Classification
( WHO,
2001 )
B-cell neoplasms
Precursor B-cell neoplasms (2 types)
Mature B-cell neoplasms (19) Diffuse large B cell
lymphoma
B-cell proliferations of uncertain malignant potential (2)
Hodgkin lymphoma
Classical Hodgkin lymphomas (4)
Nodular lymphocyte predominant Hodgkin lymphoma (1)
Lymphoma Classification
( WHO, 2001 )
B-Cell Neoplasms
I.
Precursor B-cell neoplasm : Precursor B- acute lymphoblastic
leukemia / lymphoblastic lymphoma (B-ALL, LBL)
II. Mature (peripheral) B-neoplasms
a.
B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma
b.
B-cell prolymphocytic leukemia
c.
Lymphoplasmacytic lymphoma
d.
Mantle cell lymphoma
e.
Folliculer lymphoma
f.
Splenic marginal zone B-cell lymphoma (+ villous
lymphocytes)
g.
Hairy cell leukemia
h.
Plasma cell myeloma/plasmacytoma
i.
Extranodal marginal zone B-cell lymphoma of MALT type
j
Nodal marginal zone B-cell lymphoma (+ monocytoid B cells)
k.
Diffuse large B-cell lymphoma
l.
Burkitts lymphoma/Burkitt cell leukemia
A.
Non-Hodgkins Lymphomas
DLBC
L
35%
Klasifikasi WF ( 1982 )
Low grade malignancy
Small lymphocytic / plasmacytoid
Follicular, predominantly small cleaved cell
Follicular, mixed small cleaved and large cell
Intermediete grade malignancy
Follicular, predominantly large cell
Difuse, small cleaved cell
Diffuse, mixed small and large cell
High grade malignancy
Large cell, immunoblastic
Lymphoblastic
Small, non cleaved cell
PENDEKATAN DIAGNOSTIK
1. Anamnesis
Umum
Khusus
2. Pemeriksaan fisik
Pembesaran KGB
Kelainan / pembesaran organ
Laboratorium
* Rutin Darah perifer lengkap ( DPL ),
Gambaran darah tepi ( GDT )
Urine lengkap
* Kimia Klinik
* Imunophenotyping parafin panel CD 20,
CD 3
Radiologi
* Foto torak CT Scan torak
* USG Abdomen CT Scan abdomen
* Limfografi
Biopsi KGB
PENATALAKSANAAN
1. Radioterapi
2. Radioterapi + Kemoterapi
3. Kemoterapi
Generasi Pertama
Cyclophosphamide 750 mg IV hari 1
Oncovin 1,4 mg IV hari 1
Adriamisin 50 mg IV hari 1
Prednison oral
4X20mg hari 1 5, 3 X 20 mg hr ke 6, 2 X 20 mg hr ke 7, 1 X 20 mg
hr ke 8
Penambahan Anti CD 20 Rituximab 375 / m2
siklus diulangi setiap 21 hari selama 6 siklus
Generasi dua
* M-Bacod, MOPP, COPBLAM, CAP-BOP
Generasi tiga
* MACOP B, COPBLAM III, COPBLAM IV, CHOP-Bleo/CMED
relaps : salvage teraphy
MANAGEMENT
CHOP Regimen
Cyclophosphamide 750mg/m2, iv, day 1
Doxorubicine 50mg/m2, iv, day 1
Vincristine 1.4mg/m2, max. dose 2mg, iv, day1
Prednisone 100 mg/day, oral, days 1-5
6-8 cycles, 3-weekly schedule
OR 80%-90%, CR 50%-60%
Curative < 40%
with
a good efficacy
100
CHOP
MACOP-B
ProMACE-CytaBOM
m-BACOD
80
60
40
20
0
10
15
3 weeks
8 cycles
MabThera + CHOP
375mg/m
Coiffier B, et al. N Engl J Med 2002;346:23543
CD 20 (+) RITUXIMAB +
CHOP
PENATALAKSANAAN
1. Radioterapi
2. Radioterapi +
Kemoterapi
3. Kemoterapi
KEMOTERAPI
First choice
Adriamicyn 25 mg/m2 d1,15
Bleomycin 10 u/m2 d1,15
Vinblastin 6 mg/m2 d1,15
Dacarbazin 375 mg/m2 d1,15
Alternatif
BEACOPP, Stanford V
KEMOTERAPI
FASE PERTUMBUHAN SEL
KANKER
M
G2
G1
G0
KLASIFIKASI KEMOTERAPI
GOLONGAN
SUB
GOLONGAN
ALKILATOR
MUSTAR NITROGEN
DERIVAT ETILENAMIN
ALKIL SULFONAT
NITROSURIA
ANTI
METABOLIT
ANALOG PIRIMIDIN
ANALOG PURIN
ANTAGONIS FOLAT
ALKALOID VINKA
ANTIBIOTIK
ENZIM
VINBLASTIN, VINKRISTIN
DAKTINOMISIN, MITOMISIN,
ANTRASIKLIN : DAUNORUBISIN & DOXORUBISIN
L-ASPARAGINASE
ADRENOKORTIKOID
PROGESTIN
ESTROGEN
ANDROGEN
PREDNISON
HIDROKSIPROGESTERON, MEGESTROL
DIETILSTILBESTEROL, ETINILESTRADIOL
TESTOTERON, FLUOKSIMESTERON
FOSFOR
YODIUM
NATRIUM FOSFAT
NATRIUM YODIDA
SUBSTITUSI UREA
HIDROKSIUREA
PROKARBAZIN
PRODUK
ALAMIAH
HORMON
ISOTOP
RADIOAKTIF
LAIN-LAIN
DERIVAT METIHIDRAZIN
OBAT
PERHATIAN
TOKSISITAS OBAT
SST, SALURAN CERNA, SEL FOLIKEL RAMBUT
KONTRA INDIKASI
* KU BURUK SKALA KARNOFSKY KURANG 30
* DEPRESI SST
* KEMOTERAPI SEBELUMNYA KURANG 3 MINGGU
* INFEKSI AKUT
* KEHAMILAN TRIMESTER 1
* PEMBEDAHAN BESAR ( 10 20 HARI )
* GGN PSIKIATRIK BERAT
* TAK MUNGKIN EVALUASI YANG BAIK / LENGKAP
RISIKO LAIN
KARNOFSKY SCALE
100 %
90 %
80 %
70 %
60 %
50 %
40 %
30 %
20 %
10 %
0%
ECOG SCALE
0
1
2
3
4
5
: NORMAL
: GEJALA ADA, TERTOLERANSI
: TAK BISA AKTIFITAS NORMAL, KURANG 50 % BEDREST
: SAKIT BERAT, LEBIH 50 %,BEDREST, MASIH MAMPU BERDIRI
: SAKIT AMAT BERAT, 100 % DITEMPAT TIDUR
: MENINGGAL
PERSIAPAN KEMOTERAPI
1.
2.
3.
4.
5.
6.
7.
8.
9.
INFORM CONSENT
INFORMASI MANFAAT DAN EFEK SAMPING
PEMERIKSAAN DARAH
* HB, > 10 GR%, LEU > 5000 /MM3, TROMB > 100.000/MM3
* SGOT, SGPT, UREUM, KREATININ, ASAM URAT
K/P EKG / EKOKARDIOGRAFI
DIET MB TKTP
INFUS NACL 0,9%, DEXTROSE 5 %
ANTIMUNTAH, METOKLORPAMID / ONDASETRON
LIHAT PROTAP PENYAKIT
MONITORING EFEK SAMPING
THANK YOU